Purpose Despite advances in personalizing the efficacy of cancer therapy, our ability to
identify patients at risk of severe treatment side effects and provide individualized supportive …

Pancreatic ductal adenocarcinoma (PDAC) ranks among the 15 most prevalent cancers
globally, characterized by aggressive growth and late-stage diagnosis. Advances in imaging …

PURPOSE: Improving local control is critical to improving survival and quality of life for
patients with locally advanced unresectable pancreatic cancer (LAPC). However, previous …

Objectives: The role of radiation therapy in the management of unresectable pancreatic
cancer is controversial. One concern about concurrent chemoradiation relates to the timing …

Purpose: Uncontrolled local growth is the cause of death in∼ 30% of patients with
unresectable pancreatic cancers. The addition of standard‐dose radiotherapy to …

Objectives Survival in patients with locally advanced unresectable pancreatic cancer
(LAUPC) is poor, and local recurrence continues to be a major problem in the management …

Background The purpose was to retrospectively evaluate the effect of intensity-modulated
radiotherapy (IMRT) on gastrointestinal (GI) toxicities and outcomes compared to three …

Radiotherapy (RT) has been the standard of care for treating a multitude of cancer types.
Radiation-induced gastric injury (RIGI) is a common complication of RT for thoracic and …

Background and purpose We evaluated the robustness of carbon ion therapy for pancreatic
cancer patients by investigating the impact of interfractional anatomical changes on the …

Background and purpose Hypofractionated radiotherapy (RT) of pancreatic
adenocarcinoma is limited by the tolerance of adjacent normal tissues. A better …